Destination Matters More: Relapse following Hospital-Based Treatment of Substance Use Disorders With and Without Co-Occurring Disorders

被引:1
|
作者
Andreu, Magali [1 ,2 ,3 ]
Balcells-Olivero, Merce [1 ,2 ]
Alcaraz, Noelia [1 ,2 ]
Marco, Oriol [1 ,2 ]
Bueno, Laura [1 ,2 ]
Gual, Antoni [1 ,2 ]
Barrio, Pablo [1 ,2 ,4 ]
机构
[1] Hosp Clin & Univ Barcelona, Clin Inst Neurosci Psychiat & Psychol Serv, Dept Psychiat, Res Grp Clin Addict GRAC GRE, Barcelona, Spain
[2] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain
[3] Univ Barcelona, Doctoral Program Med & Translat Res, Barcelona, Spain
[4] Clin Hosp Barcelona, Addict Behav Unit, Rossello 149, Barcelona, Spain
关键词
Co-occurring disorders; substance use disorder; relapse; abstinence; inpatient detoxification; dual diagnosis; RESIDENTIAL-TREATMENT PROGRAMS; GENDER-DIFFERENCES; DUAL DIAGNOSIS; ALCOHOL DEPENDENCE; SEX-DIFFERENCES; ABUSE RELAPSE; UNITED-STATES; PROFESSIONALS; COMORBIDITY; MOTIVATION;
D O I
10.1080/15504263.2024.2311634
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objectives: Addressing substance use in psychiatric care encounters significant barriers, but the emergence of specialized services offers an opportunity to advance and scale up the integration of addiction services within psychiatric settings. However, research gaps still exist in this field, particularly in understanding the substance relapse rates of people with co-occurring disorders after a psychiatric hospitalization. This study aimed to investigate and compare the relapse rates of patients under inpatient care with exclusively addiction-related issues and those with co-occurring disorders after a hospitalization in a psychiatric ward and gain insights into differences in outcomes for these two patient groups. Methods: This retrospective analysis examined electronic medical records of patients admitted to the Acute Psychiatry Ward of the Hospital Clinic of Barcelona with a substance use disorder diagnosis between January 2019 and February 2021. Cox regression was used to identify variables independently associated with the first relapse episode. Results: From a total of 318 admissions (79.2% with psychiatric comorbidity), 76.1% relapsed during the study follow-up, with a median survival time of 54 days. Younger age, female gender, voluntary admission, and outpatient follow-up were independently associated with relapse. The presence of a co-occurring disorder was not associated with relapse. Conclusion: This study highlights the need for interventions aimed at improving post-discharge abstinence rates for addiction-related hospitalizations. It also challenges the notion that co-occurring disorders automatically imply a worsened prognosis and emphasizes the importance of addressing addiction and psychiatric comorbidity in a comprehensive, integrated, and specialized manner.
引用
收藏
页码:111 / 121
页数:11
相关论文
共 50 条
  • [1] Treatment of Co-occurring Anxiety Disorders and Substance Use Disorders
    McHugh, R. Kathryn
    HARVARD REVIEW OF PSYCHIATRY, 2015, 23 (02) : 99 - 111
  • [2] Diagnosis and treatment of co-occurring affective disorders and substance use disorders
    Myrick, H
    Cluver, J
    Swavely, S
    Peters, H
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2004, 27 (04) : 649 - +
  • [3] Treatment of Co-Occurring Psychotic and Substance Use Disorders
    Mueser, Kim T.
    Gingerich, Susan
    SOCIAL WORK IN PUBLIC HEALTH, 2013, 28 (3-4) : 424 - 439
  • [4] Co-occurring mental disorders in treatment admissions for substance use disorders in Maryland
    Patience Moyo
    Ting-Ying Huang
    Linda Simoni-Wastila
    Addiction Science & Clinical Practice, 10 (Suppl 1)
  • [5] Treatment of substance use disorders with co-occurring severe mental health disorders
    Murthy, Pratima
    Mahadevan, Jayant
    Chand, Prabhat K.
    CURRENT OPINION IN PSYCHIATRY, 2019, 32 (04) : 293 - 299
  • [6] Treatment strategies for co-occurring ADHD and substance use disorders
    Mariani, John J.
    Levin, Frances R.
    AMERICAN JOURNAL ON ADDICTIONS, 2007, 16 : 45 - 56
  • [7] Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders
    Smelson, David A.
    Dixon, Lisa
    Craig, Thomas
    Remolina, Stephen
    Batki, Steven L.
    Niv, Noosha
    Owen, Richard
    CNS DRUGS, 2008, 22 (11) : 903 - 916
  • [8] Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders
    David A. Smelson
    Lisa Dixon
    Thomas Craig
    Stephen Remolina
    Steven L. Batki
    Noosha Niv
    Richard Owen
    CNS Drugs, 2008, 22 : 903 - 916
  • [9] TREATMENT OF YOUTH SUBSTANCE USE DISORDERS WITH CO-OCCURRING DEPRESSION
    Kaminer, Yifrah
    DRUG AND ALCOHOL REVIEW, 2017, 36 : 5 - 5
  • [10] Hospitalizations and hospital charges for co-occurring substance use and mental disorders
    Ding, Kele
    Yang, Jingzhen
    Cheng, Gang
    Schiltz, Trisha
    Summers, Karen M.
    Skinstad, Anne Helene
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2011, 40 (04) : 366 - 375